Concepedia

Author

Morito Sumiya

Saitama International Medical Center

Also Known As

M SUMIYA, M Sumiya, M. Sumiya, Morito SUMIYA, Morito Sumiya

74

Publications

974

Citations

18

H-Index

57

Concepts

All Affiliations

Saitama International Medical CenterJichi Medical UniversityThe University of TokyoHokkaido University
MS

About

Morito Sumiya is an author at Saitama International Medical Center specializing in medicine, autoimmune disease, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

13

428

2

Cell Biology

4

4

180

3

Public Health

1

1

74

4

Allergy

1

1

74

5

Cellular Physiology

1

1

29

Morito Sumiya

×

26

Publications

857

Citations

17

H-Index

YearCitations

CHRONIC LYMPHOCYTIC LEUKÆMIA OF T-CELL ORIGIN ?

Morito Sumiya, Hideaki Mizoguchi, Kinori Kosaka,

The Lancet

1973

80

Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein

Masako Okawa‐Takatsuji, S Aotsuka, Misa Fujinami,

Clinical & Experimental Immunology

1999

74

Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.

Kazuo Oshimi, N Gonda, Morito Sumiya,

PubMed

1980

62

Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus.

Taku Yoshio, J Masuyama, Morito Sumiya,

PubMed

1994

62

Immunological analysis of pulmonary hypertension in connective tissue diseases.

T Nishimaki, S Aotsuka, Hirohito M. Kondo,

PubMed

1999

60

Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan.

Lisa Kotajima, S Aotsuka, Morito Sumiya,

PubMed

1996

58

Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis.

Lisa Kotajima, S Aotsuka, M Fujimani,

PubMed

1998

55

Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases

Masako Okawa‐Takatsuji, S Aotsuka, Shu Uwatoko,

Clinical & Experimental Immunology

2001

42

Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses

M. Kishi, Yoshinori Nishino, Morito Sumiya,

Journal of General Virology

1992

41

Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus

Kenji Itoh, Toshikazu Kano, Chiaki Nagashio,

Arthritis & Rheumatism

2006

35

Page 1